OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy
Maria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Maria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Showing 9 citing articles:
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update
Kylie Fletcher, Douglas B. Johnson
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008591-e008591
Open Access | Times Cited: 4
Kylie Fletcher, Douglas B. Johnson
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008591-e008591
Open Access | Times Cited: 4
The many faces of autoimmune-mediated melanocyte destruction in melanoma
Loredana Ungureanu, Alina Vasilovici, Salomea-Ruth Halmágyi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Loredana Ungureanu, Alina Vasilovici, Salomea-Ruth Halmágyi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center
João Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 1113-1128
Open Access | Times Cited: 1
João Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 1113-1128
Open Access | Times Cited: 1
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
Yanek Jiménez-Andrade, Jessica L. Flesher, Jin Mo Park
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 1011-1025
Closed Access | Times Cited: 1
Yanek Jiménez-Andrade, Jessica L. Flesher, Jin Mo Park
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 1011-1025
Closed Access | Times Cited: 1
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study
Abigail Gault, Linda Hogarth, Kristian C. Williams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Abigail Gault, Linda Hogarth, Kristian C. Williams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
Federico Venturi, Giulia Veronesi, Biagio Scotti, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3679-3679
Open Access | Times Cited: 1
Federico Venturi, Giulia Veronesi, Biagio Scotti, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3679-3679
Open Access | Times Cited: 1
Vitiligo and cutaneous malignancy: what is the risk?
Sahngeun Jenny Mun, Monisha Gupta
Pigment International (2024) Vol. 11, Iss. 3, pp. 142-150
Open Access
Sahngeun Jenny Mun, Monisha Gupta
Pigment International (2024) Vol. 11, Iss. 3, pp. 142-150
Open Access
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence
Abdulaziz M. Eshaq, Thomas W. Flanagan, Anass Abbad, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 88-88
Open Access
Abdulaziz M. Eshaq, Thomas W. Flanagan, Anass Abbad, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 88-88
Open Access
